BCL7A antibody (N-Term)
Quick Overview for BCL7A antibody (N-Term) (ABIN950637)
Target
See all BCL7A AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-30, N-Term
-
Specificity
- This antibody reacts to Bcl-7A.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCL7A
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Alternative Name
- Bcl-7A
-
Background
- This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.Synonyms: B-cell CLL/lymphoma 7 protein family member A, BCL7A
-
Gene ID
- 605
-
NCBI Accession
- NP_001019979
Target
-